Fortress Biotech, Inc. Quarterly Net Cash Provided by (Used in) Financing Activities in USD from Q1 2013 to Q1 2024

Taxonomy & unit
us-gaap: USD
Description
Amount of cash inflow (outflow) from financing activities, including discontinued operations. Financing activity cash flows include obtaining resources from owners and providing them with a return on, and a return of, their investment; borrowing money and repaying amounts borrowed, or settling the obligation; and obtaining and paying for other resources obtained from creditors on long-term credit.
Summary
Fortress Biotech, Inc. quarterly/annual Net Cash Provided by (Used in) Financing Activities history and growth rate from Q1 2013 to Q1 2024.
  • Fortress Biotech, Inc. Net Cash Provided by (Used in) Financing Activities for the quarter ending March 31, 2024 was $27.9M, a 25.6% increase year-over-year.
  • Fortress Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2023 was $32.7M, a 56.5% decline from 2022.
  • Fortress Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2022 was $75.3M, a 49.4% decline from 2021.
  • Fortress Biotech, Inc. annual Net Cash Provided by (Used in) Financing Activities for 2021 was $149M, a 13.6% decline from 2020.
Net Cash Provided by (Used in) Financing Activities, Quarterly (USD)
Net Cash Provided by (Used in) Financing Activities, YoY Quarterly Growth (%)
Period TTM Value Value YoY Chg Change % Start Date End Date Report Filed
Q1 2024 $27.9M +$5.67M +25.6% Jan 1, 2024 Mar 31, 2024 10-Q 2024-05-15
Q1 2023 $22.2M -$27.8M -55.6% Jan 1, 2023 Mar 31, 2023 10-Q 2024-05-15
Q1 2022 $50M -$28.7M -36.5% Jan 1, 2022 Mar 31, 2022 10-Q 2023-05-15
Q1 2021 $78.7M +$55.9M +246% Jan 1, 2021 Mar 31, 2021 10-Q 2022-05-12
Q1 2020 $22.8M -$29.4M -56.3% Jan 1, 2020 Mar 31, 2020 10-Q 2021-05-17
Q1 2019 $52.1M +$12.5M +31.4% Jan 1, 2019 Mar 31, 2019 10-Q 2020-05-11
Q1 2018 $39.7M -$18.5M -31.8% Jan 1, 2018 Mar 31, 2018 10-Q 2019-05-10
Q1 2017 $58.2M Jan 1, 2017 Mar 31, 2017 10-Q 2018-05-10
Q1 2013 $11.3M Jan 1, 2013 Mar 31, 2013 10-Q 2013-05-09
* An asterisk sign (*) next to the value indicates that the value is likely invalid.